1. Home
  2. CRC vs LQDA Comparison

CRC vs LQDA Comparison

Compare CRC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$53.96

Market Cap

4.8B

Sector

Energy

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$91.70

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRC
LQDA
Founded
2014
2004
Country
United States
United States
Employees
2500
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CRC
LQDA
Price
$53.96
$91.70
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$72.57
$41.00
AVG Volume (30 Days)
740.0K
1.3M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
51.81
EPS
N/A
0.52
Revenue
N/A
$158,320,000.00
Revenue This Year
$12.37
$278.87
Revenue Next Year
N/A
$57.13
P/E Ratio
$13.50
$173.50
Revenue Growth
N/A
1031.18
52 Week Low
$43.25
$21.15
52 Week High
$71.98
$91.57

Technical Indicators

Market Signals
Indicator
CRC
LQDA
Relative Strength Index (RSI) 54.51 67.21
Support Level $50.27 $31.99
Resistance Level $54.86 N/A
Average True Range (ATR) 1.75 5.09
MACD 0.34 0.15
Stochastic Oscillator 72.84 99.45

Price Performance

Historical Comparison
CRC
LQDA

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: